Michaël Tracy

2.2k total citations
52 papers, 1.6k citations indexed

About

Michaël Tracy is a scholar working on Cancer Research, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Michaël Tracy has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 10 papers in Organic Chemistry and 7 papers in Molecular Biology. Recurrent topics in Michaël Tracy's work include Cancer, Hypoxia, and Metabolism (12 papers), Free Radicals and Antioxidants (5 papers) and Synthesis and Biological Evaluation (4 papers). Michaël Tracy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Free Radicals and Antioxidants (5 papers) and Synthesis and Biological Evaluation (4 papers). Michaël Tracy collaborates with scholars based in United States, United Kingdom and Germany. Michaël Tracy's co-authors include Steven A. Johnson, Eric O. Aboagye, Richard Wettstein, Ruben D Restrepo, Paul Workman, Peter Wardman, A B Kelson, Alexander D. Lewis, Scott E. Lukas and David Y.W. Lee and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Michaël Tracy

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaël Tracy United States 21 364 290 260 188 174 52 1.6k
Bogdan Catargi France 29 294 0.8× 291 1.0× 83 0.3× 349 1.9× 215 1.2× 85 3.4k
Lili Du China 31 819 2.3× 322 1.1× 267 1.0× 53 0.3× 225 1.3× 69 2.5k
Marco Maria Fontanella Italy 31 492 1.4× 253 0.9× 90 0.3× 186 1.0× 67 0.4× 207 3.5k
Iwona T. Dobrucki United States 17 531 1.5× 578 2.0× 224 0.9× 140 0.7× 419 2.4× 36 1.9k
Qin Chen China 22 726 2.0× 172 0.6× 142 0.5× 87 0.5× 118 0.7× 69 1.8k
Sang Hoon Lee South Korea 23 269 0.7× 116 0.4× 107 0.4× 129 0.7× 90 0.5× 83 1.6k
Byung Chul Lee South Korea 21 344 0.9× 106 0.4× 79 0.3× 450 2.4× 75 0.4× 99 1.6k
Ulrich Beyer Switzerland 27 672 1.8× 260 0.9× 86 0.3× 189 1.0× 503 2.9× 49 2.4k
Carmen Garnacho Spain 19 498 1.4× 328 1.1× 74 0.3× 86 0.5× 442 2.5× 33 1.9k
Kyoko Yamamoto Japan 26 717 2.0× 378 1.3× 57 0.2× 77 0.4× 82 0.5× 150 2.5k

Countries citing papers authored by Michaël Tracy

Since Specialization
Citations

This map shows the geographic impact of Michaël Tracy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Tracy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Tracy more than expected).

Fields of papers citing papers by Michaël Tracy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Tracy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Tracy. The network helps show where Michaël Tracy may publish in the future.

Co-authorship network of co-authors of Michaël Tracy

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Tracy. A scholar is included among the top collaborators of Michaël Tracy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Tracy. Michaël Tracy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oza, Amit M., Maria Del Pilar Estevez-Diz, Eva‐Maria Grischke, et al.. (2020). A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive TP53 -mutant Ovarian Cancer. Clinical Cancer Research. 26(18). 4767–4776. 89 indexed citations
2.
Lukas, Scott E., David M. Penetar, Zhaohui Su, et al.. (2012). A standardized kudzu extract (NPI-031) reduces alcohol consumption in nontreatment-seeking male heavy drinkers. Psychopharmacology. 226(1). 65–73. 31 indexed citations
3.
Restrepo, Ruben D, et al.. (2011). Incentive Spirometry: 2011. Respiratory Care. 56(10). 1600–1604. 120 indexed citations
4.
Geeganage, Chamila, Michaël Tracy, Timothy J. England, et al.. (2010). Relationship Between Baseline Blood Pressure Parameters (Including Mean Pressure, Pulse Pressure, and Variability) and Early Outcome After Stroke. Stroke. 42(2). 491–493. 81 indexed citations
5.
Geeganage, Chamila, et al.. (2010). Blood pressure reduction and cardiovascular prevention: meta-regression using ordered categorical (ordinal) event data. Journal of Hypertension. 28(10). 1995–1999. 2 indexed citations
6.
Penetar, David M., Christian J. Teter, Zhongze Ma, et al.. (2006). Pharmacokinetic Profile of the Isoflavone Puerarin After Acute and Repeated Administration of a Novel Kudzu Extract to Human Volunteers. The Journal of Alternative and Complementary Medicine. 12(6). 543–548. 26 indexed citations
7.
Damon, LE, HS Rugo, AR Zander, et al.. (2000). High-dose chemotherapy (CTM) for breast cancer. Bone Marrow Transplantation. 26(3). 257–268. 12 indexed citations
8.
Tracy, Michaël. (1999). Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials. 20(11). 1057–1062. 350 indexed citations
9.
Tracy, Michaël, et al.. (1999). Using group decision support systems to brainstorm and evaluate prospective consultation interventions.. Consulting psychology journal. 51(3). 181–190. 1 indexed citations
10.
11.
Kelson, A B, Jonathan P. McNamara, Ambarish Pandey, et al.. (1998). 1,2,4-Benzotriazine 1,4-dioxides. An important class of hypoxic cytotoxins with antitumor activity.. PubMed. 13(6). 575–92. 29 indexed citations
12.
Aboagye, Eric O., et al.. (1997). Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.. PubMed. 57(15). 3314–8. 38 indexed citations
13.
14.
Aboagye, Eric O., et al.. (1995). Development and validation of a solid-phase extraction and high-performance liquid chromatographic assay for a novel fluorinated 2-nitroimidazole hypoxia probe (SR-4554) in Balb/c mouse plasma. Journal of Chromatography B Biomedical Sciences and Applications. 672(1). 125–132. 3 indexed citations
15.
Wardman, Peter, Madeleine F. Dennis, Steven A. Everett, et al.. (1995). Radicals from one-electron reduction of nitro compounds, aromatic N-oxides and quinones: the kinetic basis for hypoxia-selective, bioreductive drugs. Biochemical Society Symposia. 61. 171–194. 51 indexed citations
16.
Webster, Keith A., Ilona Bódi, J.P. McNamara, et al.. (1993). Negative Lusitropy and Abnormal Calcium Handling in Hypoxic Cardiac Myocytes Exposed to the Calcium-Sensitizer EMD 53998. Journal of Molecular and Cellular Cardiology. 25(7). 747–751. 12 indexed citations
17.
Zeman, Elaine M., et al.. (1989). Structure-activity relationships for benzotriazine DI-N-oxides. International Journal of Radiation Oncology*Biology*Physics. 16(4). 977–981. 55 indexed citations
18.
19.
Acton, Edward M., Kenneth J. Ryan, & Michaël Tracy. (1984). Synthetic approach to anthracyclinone C-glycosides. Tetrahedron Letters. 25(50). 5743–5746. 12 indexed citations
20.
Tracy, Michaël, et al.. (1973). Special Education as Experimental Education: A New Conceptualization. Exceptional Children. 40(1). 29–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bogdan Catargi Breakdown of academic impact, for papers by Lili Du Breakdown of academic impact, for papers by Marco Maria Fontanella Breakdown of academic impact, for papers by Iwona T. Dobrucki Breakdown of academic impact, for papers by Qin Chen Breakdown of academic impact, for papers by Sang Hoon Lee Breakdown of academic impact, for papers by Byung Chul Lee Breakdown of academic impact, for papers by Ulrich Beyer Breakdown of academic impact, for papers by Carmen Garnacho Breakdown of academic impact, for papers by Kyoko Yamamoto
Rankless by CCL
2026